ATLANTA, March 22, 2018 -- Sharecare, the digital health company helping people manage all their health in one place, today announced that its co-founder, chairman and CEO Jeff Arnold will interview David Hoke, Walmart’s senior director of Associate Health and Wellbeing, at The Conference Board’s 18th Annual Employee Health Care Conference in San Diego.
|
|||||
Scheduled for Tuesday, March 27 at 1:40 p.m. PT, Hoke will discuss Walmart’s innovative approach to improving the health and wellbeing of their workforce; and how they are partnering with Sharecare to engage with and increase the personal capacity of Walmart’s population and the broader communities in which the company operates.
“The complex and varied healthcare challenges that employers face today require a willingness to collaborate, think differently and design comprehensive healthcare strategies through the lens of consumerism,” said Arnold. “We are proud to have partners like Walmart who not only are committed to improving the wellbeing of each of their associates, but also can inspire other employers to take more innovative, provocative approaches to fostering healthier workforces and communities.”
| WHEN: | Tuesday, March 27 at 1:40 p.m. PT |
| WHERE: | Hilton San Diego Bayfront, Sapphire Ballroom |
| WHAT: | Concurrent Session F3: Creating Sustained Engagement Through Personalized Employee Health |
| WHO: | Jeff Arnold, Sharecare’s co-founder, chairman and CEO, and David Hoke, Walmart’s senior director of Associate Health and Wellbeing |
To learn more about Sharecare’s ability to deliver real engagement and meaningful change for employers, attendees of The Conference Board in San Diego can visit the Sharecare team in Booth #31 in Sapphire AEI on Level 4 of the Hilton San Diego Bayfront.
About Sharecare
Sharecare is the digital health company that helps people manage all their health in one place. The Sharecare platform provides each person – no matter where they are in their health journey – with a comprehensive and personalized health profile where they can dynamically and easily connect to the information, evidence-based programs and health professionals they need to live their healthiest, happiest and most productive life. In addition to providing individual consumers with direct access to award-winning and innovative frictionless technologies, scientifically validated clinical protocols and best-in-class coaching tools, Sharecare also helps providers, employers and health plans effectively scale outcomes-based health and wellness solutions across their entire populations. To learn more, visit www.sharecare.com.
Media Contact:
Sharecare PR Team
[email protected]
404.665.4305
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/e7c7389b-6d52-48d2-adf5-b5b0ff40d5d6


DHL Q2 Profit Jumps 24% as Express Business Drives Growth
Apple Restores Telegram to App Store After Content Policy Violation
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Jetstar to Charge for Overhead Cabin Bags From February
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 



